Alchemia

Alchemia (ACL)

Stock Code

ACL

Stock Exchange

ax

Alchemia (ACL) is a biotechnology company. The Company’s principal activities incorporate the development of carbohydrate-based molecules for therapeutic applications, based on its drug discovery and synthesis technologies. Alchemia was listed on the Australian Stock Exchange ASX on 23rd of December, 2003. Alchemia along with its subsidiaries is engaged in the research and development of new human pharmaceuticals.

Alchemia Dividends

1 September, 2010 - 13:29

Read up on the dividend history for ALCHEMIA LIMITED. Dividends are a payment declared by a company's board of directors and given to its shareholders from the company's current or retained earnings. Dividends are usually released as cash (cash dividend). Dividends provide an incentive to own shares in the company. Companies are not required to pay dividends. You are eligible to receive ACL dividends if you own the ALCHEMIA LIMITED shares on the ex-dividend date.

Alchemia Dividends

1 September, 2010 - 13:01

Read up on the dividend history for ALCHEMIA LIMITED. Dividends are a payment declared by a company's board of directors and given to its shareholders from the company's current or retained earnings. Dividends are usually released as cash (cash dividend). Dividends provide an incentive to own shares in the company. Companies are not required to pay dividends. You are eligible to receive ACL dividends if you own the ALCHEMIA LIMITED shares on the ex-dividend date.

Alchemia (ACL) Stock Recommendation


ABN Amro has rated the Alchemia (ACL) stock with a Buy and a valuation of $3.55 per share. The broker has noted that the company has also entered a collaboration with another European drug company to search for new drug candidates, providing future upside potential if any successful developments are made.

Syndicate content

Recommended Websites